Prescription drug · ANDA
Macitentan NDC 46708-373
Macitentan 10 mg/1 · Tablet, Film coated · Oral · Alembic Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 46708-373-30 | 4670803733046708037330 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-373-30)Marketed from Jun 6, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Macitentan
- Generic name (nonproprietary)
- macitentan
- Active ingredients
- Macitentan — 10 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Alembic Pharmaceuticals LimitedNDC labeler code 46708
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211128
- Marketing start
- Listing expires
- Other FDA classes
- Endothelin Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 46708-373_4d9d9a84-6853-4004-b20a-8849b34453a4SPL ID 4d9d9a84-6853-4004-b20a-8849b34453a4SPL set ID 4d9d9a84-6853-4004-b20a-8849b34453a4RxCUI 1442137UNII Z9K9Y9WMVL
- Pharmacologic class
- Endothelin Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N446708037330followed by a unit qualifier and the quantityPackage 46708-0373-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Macitentan tablets are an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adults to reduce the risk of disease progression and hospitalization for PAH ( 1.1 ). 1.1 Pulmonary Arterial Hypertension Macitentan tablets are an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adults to reduce the risks of disease progression and hospitalization for PAH. Effectiveness was established in a long-term study in PAH patients with predominantly WHO Functional Class II-III symptoms treated for an average of 2 years. Patients had idiopathic and heritable PAH (57…
Excerpt only. Read the full label for complete information.
About NDC 46708-373
- What is NDC 46708-373?
- 46708-373 is the product NDC for Macitentan, Macitentan 10 mg/1 tablet, film coated, listed with the FDA by Alembic Pharmaceuticals Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Macitentan.
- What is the active ingredient?
- Macitentan.
- Who is the labeler?
- Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Macitentan?
- 13 other product NDCs are listed under this name. See all Macitentan NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Macitentan products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | ANI Pharmaceuticals, Inc. | 70954-025 | 70954-0025-1070954-0025-20 |
| macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | Apotex Corp. | 60505-4644 | 60505-4644-03 |
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | Mylan Pharmaceuticals Inc. | 0378-0606 | 00378-0606-93 |
| macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals, Inc. | 0480-0915 | 00480-0915-56 |
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 59651-147 | 59651-0147-30 |
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | Amneal Pharmaceuticals NY LLC | 69238-1327 | 69238-1327-03 |
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | Sun Pharmaceutical Industries, Inc. | 47335-070 | 47335-0070-1547335-0070-30 |
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-373 | 62332-0373-30 |
| Macitentan | Macitentan 10 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | 13668-542 | 13668-0542-0513668-0542-3013668-0542-90 |
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | Laurus Labs Limited | 42385-907 | 42385-0907-1542385-0907-30 |
Other NDCs under ANDA 211128
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-373 |